Gluteal activation with or without core strengthening for Dead Butt Syndrome

Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome

NA · Riphah International University · NCT07576114

This trial tests whether adding core-strengthening exercises to gluteal activation helps adults with Dead Butt Syndrome reduce pain, improve strength, and sit or walk more comfortably.

Quick facts

PhaseNA
Study typeInterventional
Enrollment40 (estimated)
Ages18 Years to 55 Years
SexAll
SponsorRiphah International University (other)
Locations1 site (Islamabad)
Trial IDNCT07576114 on ClinicalTrials.gov

What this trial studies

This randomized controlled trial will enroll 40 adults with subacute or chronic Dead Butt Syndrome and randomly assign 20 participants to gluteal activation exercises and 20 to gluteal activation plus core-strengthening exercises. Participants will be recruited by convenience sampling and randomized using a sealed-envelope method, with interventions delivered at regional rehabilitation centers. Outcomes will include measures of gluteal muscle activation, core strength, and patient-reported symptoms and function, tracked over a 12-month period. The trial is sponsored by Riphah International University and conducted at participating centers in the Islamabad–Rawalpindi area.

Who should consider this trial

Good fit: Adults with Dead Butt Syndrome for more than six weeks who are sedentary to moderately active and not currently doing focused gluteal or core training are ideal candidates.

Not a fit: People who are pregnant, have diagnosed hip labral tears, piriformis syndrome, unrelated sciatica, major degenerative or neurological conditions, recent significant spinal surgery, or who already exercise regularly may not benefit from this protocol.

Why it matters

Potential benefit: If successful, combining core strengthening with gluteal activation could reduce buttock pain and weakness and improve sitting tolerance and walking function.

How similar studies have performed: Related exercise programs targeting hip/glute activation and core strengthening have shown modest benefits for hip- and low-back–related pain, but randomized evidence specific to Dead Butt Syndrome is limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Symptoms persisting for more than 6 weeks (subacute or chronic cases).
* Sedentary to moderately active individuals (i.e., not involved in heavy gluteal-strengthening or core training for at least 3 months prior to the study). vParticipants will be diagnosed with Dead Butt Syndrome based on the presence of at least two out of three of the following criteria:
* Self-reported dull ache, discomfort, or tightness in the gluteal region worsened with prolonged sitting or walking.
* Positive Trendelenburg Test
* ≤ 4/5 on the standard MRC grading scale

Exclusion Criteria:

* Pregnancy or plans to become pregnant during the study period.
* Diagnosed hip labral tears, piriformis syndrome, or sciatica unrelated to gluteal amnesia.
* Degenerative or neurological conditions such as osteoarthritis, multiple sclerosis, stroke, or spinal cord injury.
* History of significant spinal trauma or surgery in the past 12 months.
* Engagement in regular physical exercise or participation in rehabilitation programs within the last 6 months.

Where this trial is running

Islamabad

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Syndrome, Dead Butt Syndrome, Gluteal Muscle Activation, Core Strengthening

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.